
### [Orphanet:653](http://www.orpha.net/ORDO/Orphanet_653)
**Label:** Multiple endocrine neoplasia type 2

**Subclasses:** [Orphanet:247709](http://www.orpha.net/ORDO/Orphanet_247709) (Multiple endocrine neoplasia type 2B), [Orphanet:247698](http://www.orpha.net/ORDO/Orphanet_247698) (Multiple endocrine neoplasia type 2A), [Orphanet:99361](http://www.orpha.net/ORDO/Orphanet_99361) (Familial medullary thyroid carcinoma), 

**Corr. equiv. classes:** [Orphanet:247698](http://www.orpha.net/ORDO/Orphanet_247698), [OMIM:162300](http://purl.obolibrary.org/obo/OMIM_162300), [Orphanet:99361](http://www.orpha.net/ORDO/Orphanet_99361), [OMIM:155240](http://purl.obolibrary.org/obo/OMIM_155240), [Orphanet:247709](http://www.orpha.net/ORDO/Orphanet_247709), [OMIM:171400](http://purl.obolibrary.org/obo/OMIM_171400), 

**Class expressions from DL-Learner:**

- [HP:0000006](http://purl.obolibrary.org/obo/HP_0000006) (Autosomal dominant inheritance) and [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) 75.00%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) 75.00%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0100530](http://purl.obolibrary.org/obo/HP_0100530) (Abnormality of calcium-phosphate metabolism) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0011976](http://purl.obolibrary.org/obo/HP_0011976) (Elevated urinary catecholamines) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0011281](http://purl.obolibrary.org/obo/HP_0011281) (Abnormality of urine catecholamine concentration) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0011277](http://purl.obolibrary.org/obo/HP_0011277) (Abnormality of the urinary system physiology) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0003639](http://purl.obolibrary.org/obo/HP_0003639) (Elevated urinary epinephrine) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0003528](http://purl.obolibrary.org/obo/HP_0003528) (Elevated calcitonin) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0003110](http://purl.obolibrary.org/obo/HP_0003110) (Abnormality of urine homeostasis) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0100530](http://purl.obolibrary.org/obo/HP_0100530) (Abnormality of calcium-phosphate metabolism) and [HP:0410008](http://purl.obolibrary.org/obo/HP_0410008) (Abnormality of the peripheral nervous system) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0100530](http://purl.obolibrary.org/obo/HP_0100530) (Abnormality of calcium-phosphate metabolism) and [HP:0100634](http://purl.obolibrary.org/obo/HP_0100634) (Neuroendocrine neoplasm) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0100007](http://purl.obolibrary.org/obo/HP_0100007) (Neoplasm of the peripheral nervous system) and [HP:0100530](http://purl.obolibrary.org/obo/HP_0100530) (Abnormality of calcium-phosphate metabolism) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0025033](http://purl.obolibrary.org/obo/HP_0025033) (Abnormality of digestive system morphology) and [HP:0100530](http://purl.obolibrary.org/obo/HP_0100530) (Abnormality of calcium-phosphate metabolism) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0100530](http://purl.obolibrary.org/obo/HP_0100530) (Abnormality of calcium-phosphate metabolism) 66.67%
- [HP:0002865](http://purl.obolibrary.org/obo/HP_0002865) (Medullary thyroid carcinoma) and [HP:0025028](http://purl.obolibrary.org/obo/HP_0025028) (Abnormality of enteric nervous system morphology) and [HP:0100530](http://purl.obolibrary.org/obo/HP_0100530) (Abnormality of calcium-phosphate metabolism) 66.67%


